MEI Board of Directors
- John H. Sadler, MD
President and CEO, Independent Dialysis Foundation, Baltimore, MD - Betty Chewning, PhD
Associate Professor, University of Wisconsin-Madison, School of Pharmacy
Director of the Sonderegger Research Center, University of Wisconsin-Madison, School of Pharmacy, Madison, WI - H. Keith Johnson, MD
Chairman of the Board, Dialysis Clinic, Inc., Nashville, TN - Michael J. Klag, MD, MPH
Dean, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD - Al W. Kraus
Strategic Business Consultant and Manager, Bryn Mawr, PA
John H. Sadler, MD
MEI Chair
President and CEO, Independent Dialysis Foundation, Baltimore, MD
Practicing clinical nephrologist, retired Associate Professor of Medicine, and Head of the Nephrology Division at the University of Maryland School of Medicine.
Co-investigator from 1994-99 on the CHOICE Study, a 5-year ESRD Patient Outcomes Research Team funded by the Agency for Health Care Policy and Research (AHCPR, now AHRQ); member of the Institute of Medicine ESRD Program Study Committee 1988-91; chair of the ESRD Health Status Outcomes Group, 1995-97. Published author of many studies on dialysis effectiveness, anemia management, and innovations in vascular access.
Betty Chewning, PhD
Associate Professor, University of Wisconsin-Madison, School of Pharmacy
Director of the Sonderegger Research Center, University of Wisconsin-Madison, School of Pharmacy, Madison, WI
Recipient of many state and federal grants, including: "Pharmaceutical Care Outcomes: The Patient's Role," funded by AHRQ; Early Head Start Program Evaluation; and studies on individuals with chronic health conditions.
Author of numerous publications, including a book promoting client self-management in chronic disease patients.
Four-time recipient of the Teacher of the Year Award from the School of Pharmacy and the UW-Madison Medical School, Department of Preventive Medicine.
H. Keith Johnson, MD
Chairman of the Board, Dialysis Clinic, Inc., Nashville, TN
Nephrologist and retired faculty member, Vanderbilt University.
Former president of both SEOPF and UNOS, the transplant registries and education organizations.
Author of several peer-reviewed articles in nephrology.
Medical Director of the Renal Transplant Program at Vanderbilt University Medical Center from 1990-99; Medical Director of the Renal Transplant Section of the Veterans Administration Medical Center, Nashville from 1972-99.
Michael J. Klag, MD, MPH
Professor of Medicine, Director, Division of General Internal Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD
Internist, epidemiologist, and specialist in preventive medicine.
Director of the Precursors Study, a prospective study of 1,337 Johns Hopkins University medical students that began in 1946; a co-principal investigator on the CHOICE study (the AHRQ patient outcomes study of ESRD); team leader of several continuing NIH grant-funded projects.
Editor-in-chief of the "Johns Hopkins Family Health Guide," member of the Editorial Board of the American Journal of Medicine, and editorial consultant to the American Journal of Epidemiology.
Al W. Kraus
Strategic Business Consultant and Manager, Bryn Mawr, PA
Former Vice President and Integration Manager for Baxter Healthcare Corporation, former President and CEO of Althin Medical, a medical device manufacturer with 900 employees.
Former President and CEO of Victor Technologies, a PC and office supplies company.
Former U.S. Manager and CEO for Gambro, manufacturer of hemodialysis, cardiovascular, and intensive care equipment.
